As of 3:59pm ET
| +0.21 / +0.44%|
The 2 analysts offering 12-month price forecasts for Natus Medical Inc have a median target of 51.00, with a high estimate of 53.00 and a low estimate of 49.00. The median estimate represents a +6.49% increase from the last price of 47.89.
The current consensus among 3 polled investment analysts is to Buy stock in Natus Medical Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.